| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6150959 | Contemporary Clinical Trials | 2015 | 13 Pages |
Abstract
Methods such as telemedicine are needed to improve monitoring, adherence, self-efficacy, and patient knowledge in IBD. If effective, telemedicine should decrease symptoms, improve quality of life, and decrease health care utilization. The burden associated with use of telemedicine for patients and providers needs to be assessed. The trial is ongoing and will be completed in July 2016.
Keywords
CCFAUMBUPMCIBDSEIMSIBDQCDAIHBICrohn's and Colitis Foundation of AmericaDSMBSF-36SCCAIGSELocus of controlClinical trialsComparative effectivenessData safety and monitoring boardinflammatory bowel diseasesCrohn's diseaseTelemedicineCrohn's Disease Activity Indexsimple clinical colitis activity indexHarvey Bradshaw indexShort Form-36LocUniversity of Pittsburgh Medical CenterInflammatory Bowel Disease QuestionnaireHATUlcerative colitis
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Raymond K. Cross, Guruprasad Jambaulikar, Patricia Langenberg, J. Kathleen Tracy, Joseph F. Collins, Jonathan Katz, Miguel Regueiro, David A. Schwartz, Charlene C. Quinn,